Tendon healing in the era of regenerative medicine: literature review.

4区 医学
Annals of translational medicine Pub Date : 2026-02-28 Epub Date: 2026-02-25 DOI:10.21037/atm-25-124
Ayobami S Ogunsola, Davis J Brady, Hailey K Bennett, John B Gordon, Ryan Zhang, Marcel G Brown, Edward C Beck, Chukwuweike U Gwam, Xue Ma
{"title":"Tendon healing in the era of regenerative medicine: literature review.","authors":"Ayobami S Ogunsola, Davis J Brady, Hailey K Bennett, John B Gordon, Ryan Zhang, Marcel G Brown, Edward C Beck, Chukwuweike U Gwam, Xue Ma","doi":"10.21037/atm-25-124","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Tendon injuries are common musculoskeletal conditions that affect both athletic and working populations. Although surgical intervention remains the mainstay of treatment for large tendon injuries, conventional approaches often result in suboptimal healing and functional outcomes. Recent evidence has shown that stem cell therapy may play a role in the management of these injuries. This review comprehensively examines the current literature on stem cell applications in tendon regeneration by analyzing both preclinical and clinical evidence. Specifically, we evaluated various stem cell populations, their characteristics, delivery mechanisms, and repair processes. Additionally, we addressed the limitations of stem cell-based therapies while highlighting emerging trends and future research directions in this rapidly evolving field.</p><p><strong>Methods: </strong>PubMed was searched for articles published in August 2025. Boolean operators \"Tendon\" OR \"Tendon repair\" OR \"Tendon regeneration\" OR \"Tendon injury\" AND \"Scaffold\" AND \"Secretomes\" OR \"Exosomes\" OR \"Stem Cells\" were used to search for articles. Inclusion criteria included studies within the last 10 years, performed on humans or animals, written in English, as well as articles considered clinical trials, meta-analyses, randomized controlled trials, reviews, or systematic reviews. We identified approximately 1,800 studies, which were screened for relevance to our topic. Additional reference screenings and targeted searches were performed to identify other relevant studies.</p><p><strong>Key content and findings: </strong>With advancements in regenerative medicine and material science, new solutions, such as the integration of stem cells and growth factors with specialized scaffolds, offer innovative solutions for tendon regeneration. Various stem cell populations, including mesenchymal stem cells (MSCs), tendon-derived stem cells (TDSCs), and perinatal stem cells (PSCs), have demonstrated potential for assisting in tendon repair. However, significant challenges persist regarding ethical considerations, safety protocols, and treatment standardization.</p><p><strong>Conclusions: </strong>Stem cell therapy represents a promising frontier in tendon healing, with growing preclinical and clinical support for its regenerative efficacy.</p>","PeriodicalId":8216,"journal":{"name":"Annals of translational medicine","volume":"14 1","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12981992/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of translational medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/atm-25-124","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: Tendon injuries are common musculoskeletal conditions that affect both athletic and working populations. Although surgical intervention remains the mainstay of treatment for large tendon injuries, conventional approaches often result in suboptimal healing and functional outcomes. Recent evidence has shown that stem cell therapy may play a role in the management of these injuries. This review comprehensively examines the current literature on stem cell applications in tendon regeneration by analyzing both preclinical and clinical evidence. Specifically, we evaluated various stem cell populations, their characteristics, delivery mechanisms, and repair processes. Additionally, we addressed the limitations of stem cell-based therapies while highlighting emerging trends and future research directions in this rapidly evolving field.

Methods: PubMed was searched for articles published in August 2025. Boolean operators "Tendon" OR "Tendon repair" OR "Tendon regeneration" OR "Tendon injury" AND "Scaffold" AND "Secretomes" OR "Exosomes" OR "Stem Cells" were used to search for articles. Inclusion criteria included studies within the last 10 years, performed on humans or animals, written in English, as well as articles considered clinical trials, meta-analyses, randomized controlled trials, reviews, or systematic reviews. We identified approximately 1,800 studies, which were screened for relevance to our topic. Additional reference screenings and targeted searches were performed to identify other relevant studies.

Key content and findings: With advancements in regenerative medicine and material science, new solutions, such as the integration of stem cells and growth factors with specialized scaffolds, offer innovative solutions for tendon regeneration. Various stem cell populations, including mesenchymal stem cells (MSCs), tendon-derived stem cells (TDSCs), and perinatal stem cells (PSCs), have demonstrated potential for assisting in tendon repair. However, significant challenges persist regarding ethical considerations, safety protocols, and treatment standardization.

Conclusions: Stem cell therapy represents a promising frontier in tendon healing, with growing preclinical and clinical support for its regenerative efficacy.

Abstract Image

Abstract Image

Abstract Image

再生医学时代的肌腱愈合:文献综述。
背景和目的:肌腱损伤是影响运动人群和工作人群的常见肌肉骨骼疾病。尽管手术干预仍然是治疗大肌腱损伤的主要方法,但传统方法往往导致愈合和功能预后不理想。最近的证据表明,干细胞治疗可能在这些损伤的管理中发挥作用。本综述通过分析临床前和临床证据,全面检查了干细胞在肌腱再生中的应用。具体来说,我们评估了各种干细胞群,它们的特性,传递机制和修复过程。此外,我们讨论了干细胞疗法的局限性,同时强调了这一快速发展领域的新兴趋势和未来的研究方向。方法:在PubMed检索2025年8月发表的文章。使用布尔运算符“肌腱”或“肌腱修复”或“肌腱再生”或“肌腱损伤”以及“支架”和“分泌体”或“外泌体”或“干细胞”来搜索文章。纳入标准包括近10年内在人类或动物身上进行的研究,以英文撰写,以及临床试验、荟萃分析、随机对照试验、综述或系统综述的文章。我们确定了大约1800项研究,这些研究与我们的主题相关。进行额外的参考筛选和目标搜索以确定其他相关研究。随着再生医学和材料科学的进步,新的解决方案,如干细胞和生长因子与专门支架的整合,为肌腱再生提供了创新的解决方案。各种干细胞群体,包括间充质干细胞(MSCs)、肌腱源性干细胞(TDSCs)和围产期干细胞(PSCs),已被证明具有帮助肌腱修复的潜力。然而,在伦理考虑、安全方案和治疗标准化方面仍然存在重大挑战。结论:干细胞治疗是肌腱愈合的一个有前途的前沿,其再生功效的临床前和临床支持越来越多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
769
期刊介绍: The Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is published quarterly (April 2013- Dec. 2013), monthly (Jan. 2014 - Feb. 2015), biweekly (March 2015-) and openly distributed worldwide. Annals of Translational Medicine is indexed in PubMed in Sept 2014 and in SCIE in 2018. Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.
 With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书